XML 30 R20.htm IDEA: XBRL DOCUMENT v3.25.3
Share-Based Compensation
 9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation Share-Based Compensation
Total share-based compensation expense was $99 million and $216 million for the three and nine months ended September 30, 2025, respectively and $76 million and $202 million for the three and nine months ended September 30, 2024, respectively. The income tax benefit realized from share-based compensation for the three and nine months ended September 30, 2025 was $11 million and $28 million, respectively. The prior period amounts were not material.
Incentive Stock Plans
Time-Based Restricted Stock and Restricted Stock Units
The following table summarizes the changes in non-vested time-based restricted stock and restricted stock units for the nine months ended September 30, 2025:
Number
of shares
(in thousands)		Weighted
average
grant-date
fair value
Non-vested as of December 31, 20248,456$32.94 
Granted99446.45 
Vested(3,407)33.33 
Forfeited(132)35.49 
Non-vested as of September 30, 20255,911$34.93 
Performance-Based Restricted Stock Units
The following table summarizes the changes in non-vested performance-based restricted stock units for the nine months ended September 30, 2025:
Number
of shares
(in thousands)		Weighted
average
grant-date
fair value
Non-vested as of December 31, 20244,040$33.28 
Granted1,50750.27 
Vested(1,630)33.71 
Performance adjustments1,14448.02 
Forfeited(71)47.40 
Non-vested as of September 30, 20254,990$41.49 
Stock Options
During the nine months ended September 30, 2025, 1.3 million options were exercised and 7 thousand options were forfeited and expired with a weighted-average exercise price of $24.14 and $22.01, respectively. As of September 30, 2025, 2.9 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $24.20, weighted average remaining contractual term of 3.6 years and aggregate intrinsic value of $169 million. As of December 31, 2024, 4.2 million options were outstanding, vested and exercisable, with a weighted-average exercise price of $24.18.